National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA.
Laboratory Genetic Metabolic Diseases, Amsterdam UMC, University of Amsterdam, Department of Clinical Chemistry and Pediatrics, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam, The Netherlands.
J Inherit Metab Dis. 2021 Jul;44(4):809-825. doi: 10.1002/jimd.12369. Epub 2021 Mar 2.
Over 80 human diseases have been attributed to defects in complex lipid metabolism. A majority of them have been reported recently in the setting of rapid advances in genomic technology and their increased use in clinical settings. Lipids are ubiquitous in human biology and play roles in many cellular and intercellular processes. While inborn errors in lipid metabolism can affect every organ system with many examples of genetic heterogeneity and pleiotropy, the clinical manifestations of many of these disorders can be explained based on the disruption of the metabolic pathway involved. In this review, we will discuss the physiological function of major pathways in complex lipid metabolism, including nonlysosomal sphingolipid metabolism, acylceramide metabolism, de novo phospholipid synthesis, phospholipid remodeling, phosphatidylinositol metabolism, mitochondrial cardiolipin synthesis and remodeling, and ether lipid metabolism as well as common clinical phenotypes associated with each.
已有 80 多种人类疾病被归因于复杂脂质代谢缺陷。其中大多数是在基因组技术快速发展及其在临床环境中日益广泛应用的背景下最近报道的。脂质在人类生物学中无处不在,在许多细胞和细胞间过程中发挥作用。虽然脂质代谢的先天性缺陷会影响每个器官系统,且有许多遗传异质性和多效性的例子,但这些疾病的许多临床表现可以根据所涉及的代谢途径的中断来解释。在这篇综述中,我们将讨论复杂脂质代谢中主要途径的生理功能,包括非溶酶体鞘脂代谢、酰基神经酰胺代谢、从头磷脂合成、磷脂重塑、磷酸肌醇代谢、线粒体心磷脂合成和重塑以及醚脂质代谢,以及与每种代谢相关的常见临床表型。